[Molecular risk markers for malignant transformation of oral mucosal leukoplakia ].
L O
LO
Skorodumova
A A
AA
Muriaev
E V
EV
Volodina
S Iu
SIu
Ivanov
N V
NV
Gnuchev
G P
GP
Georgiev
S S
SS
Larin
D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism*; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000378:metabolism* / Q000473:pathology; D003937:Diagnosis, Differential; D006801:Humans; D051034:Inhibitor of Apoptosis Proteins / Q000378:metabolism; D007972:Leukoplakia, Oral / Q000235:genetics / Q000378:metabolism* / Q000473:pathology*; D019656:Loss of Heterozygosity; D020781:Matrix Metalloproteinase 1 / Q000378:metabolism; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism; D008562:Membrane Glycoproteins / Q000378:metabolism; D009061:Mouth Mucosa / Q000378:metabolism / Q000473:pathology; D009062:Mouth Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D011003:Ploidies; D011237:Predictive Value of Tests; D018570:Risk Assessment; D012307:Risk Factors; D000077022:Survivin; D014157:Transcription Factors / Q000378:metabolism; D025521:Tumor Suppressor Proteins / Q000378:metabolism; D000098853:Podoplanin
D014408:Biomarkers, Tumor; D051034:Inhibitor of Apoptosis Proteins; D020781:Matrix Metalloproteinase 1; D020780:Matrix Metalloproteinase 9; D008562:Membrane Glycoproteins; D000077022:Survivin; D014157:Transcription Factors; D025521:Tumor Suppressor Proteins; C107489:BIRC5 protein, human; C117468:PDPN protein, human; D000098853:Podoplanin; C115051:TP63 protein, human; C522360:MMP1 protein, human